Key Financial Data Of Group

JCR Pharmaceuticals Co.,Ltd. - Filing #7360123

Concept 2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
Key financial data of group
Business results of group
Net sales
34,343,000,000 JPY
34,343,000,000 JPY
51,081,000,000 JPY
51,082,000,000 JPY
30,085,000,000 JPY
30,085,000,000 JPY
24,725,000,000 JPY
24,781,000,000 JPY
22,910,000,000 JPY
23,160,000,000 JPY
Ordinary profit (loss)
5,284,000,000 JPY
5,418,000,000 JPY
20,425,000,000 JPY
20,512,000,000 JPY
8,594,000,000 JPY
8,488,000,000 JPY
3,342,000,000 JPY
3,293,000,000 JPY
5,031,000,000 JPY
5,068,000,000 JPY
Profit (loss) attributable to owners of parent
3,772,000,000 JPY
14,507,000,000 JPY
6,892,000,000 JPY
2,678,000,000 JPY
3,715,000,000 JPY
Comprehensive income
3,881,000,000 JPY
14,514,000,000 JPY
6,841,000,000 JPY
2,504,000,000 JPY
4,008,000,000 JPY
Net assets
52,006,000,000 JPY
52,413,000,000 JPY
51,089,000,000 JPY
50,939,000,000 JPY
38,557,000,000 JPY
38,546,000,000 JPY
32,579,000,000 JPY
32,278,000,000 JPY
30,874,000,000 JPY
30,524,000,000 JPY
Total assets
94,551,000,000 JPY
94,937,000,000 JPY
97,134,000,000 JPY
97,033,000,000 JPY
73,784,000,000 JPY
73,727,000,000 JPY
47,775,000,000 JPY
47,440,000,000 JPY
42,516,000,000 JPY
42,072,000,000 JPY
Net assets per share
410.86
412.11
406.57
407.02
306.31
307.64
257.92
257.01
245.54
244.24
Basic earnings (loss) per share
29.67
30.35
116.77
117.26
57.33
55.81
22.23
21.72
31.08
30.17
Diluted earnings per share
29.54
30.22
116.31
116.80
57.05
55.53
22.10
21.59
30.90
30.00
Equity-to-asset ratio
0.542 xbrli:pure
0.542 xbrli:pure
0.518 xbrli:pure
0.519 xbrli:pure
0.513 xbrli:pure
0.516 xbrli:pure
0.666 xbrli:pure
0.668 xbrli:pure
0.711 xbrli:pure
0.715 xbrli:pure
Rate of return on equity
0.073 xbrli:pure
0.074 xbrli:pure
0.327 xbrli:pure
0.329 xbrli:pure
0.203 xbrli:pure
0.198 xbrli:pure
0.089 xbrli:pure
0.086 xbrli:pure
0.135 xbrli:pure
0.130 xbrli:pure
Price-earnings ratio
47.6 xbrli:pure
46.6 xbrli:pure
19.3 xbrli:pure
19.2 xbrli:pure
62.5 xbrli:pure
64.2 xbrli:pure
105.9 xbrli:pure
108.4 xbrli:pure
52.4 xbrli:pure
54.0 xbrli:pure
Net cash provided by (used in) operating activities
-5,500,000,000 JPY
9,289,000,000 JPY
10,341,000,000 JPY
4,927,000,000 JPY
3,905,000,000 JPY
Net cash provided by (used in) investing activities
-15,002,000,000 JPY
-3,250,000,000 JPY
-3,290,000,000 JPY
-4,161,000,000 JPY
240,000,000 JPY
Net cash provided by (used in) financing activities
1,948,000,000 JPY
-2,179,000,000 JPY
8,304,000,000 JPY
2,048,000,000 JPY
-917,000,000 JPY
Cash and cash equivalents
13,278,000,000 JPY
30,733,000,000 JPY
26,260,000,000 JPY
10,928,000,000 JPY
8,091,000,000 JPY
Number of employees
854 xbrli:pure
879 xbrli:pure
854 xbrli:pure
879 xbrli:pure
816 xbrli:pure
797 xbrli:pure
732 xbrli:pure
719 xbrli:pure
667 xbrli:pure
654 xbrli:pure
632 xbrli:pure
613 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.